Senate Passes Historic Bill that Would Let Medicare Negotiate Some Drugs’ Prices

Sen. Chuck Schumer (D-NY) speaking on Senate floor
Senate Majority Leader Chuck Schumer (D-N.Y.) opens debate Sunday on historic legislation that would let Medicare negotiate prices on a small number of high-cost single-source drugs. The House is expected to pass the bill this Friday.

The U.S. Senate on Sunday passed historic legislation to let Medicare negotiate the prices of a small number of costly medicines and require drug manufacturers to pay Medicare rebates when prices paid by Medicare rise faster than inflation.

Language in

Read More »

Vermont Passes Bill Enhancing 340B Anti-Discriminatory Protections but Measure Aimed at Drug Manufacturers Fails

Vermont State House building
Vermont recently extended its prohibition on discrimination by PBMs against 340B entities but did not require drug manufacturers to provide 340B-priced drugs to contract pharmacies.

The state of Vermont has passed a bill extending its prohibition on discrimination by pharmacy benefit managers (PBMs) against 340B covered entities, which was originally passed in June 2021 as part of the state’s 2022 budget. 

The bill was quietly

Read More »

Civica Rx Subsidiary Offers First Low-Cost Generic Drug in Outpatient Pharmacy Space, with More to Come

CivicaScript wordmark and logo
CivicaScript launched its first low-cost generic drug available in the outpatient pharmacy setting: abiraterone acetate (brand name Zytiga) used to treat metastatic prostate cancer.

CivicaScript, a unit of hospital-owned nonprofit drug company Civica Rx, has launched its first low-cost generic drug available in the outpatient pharmacy setting: abiraterone acetate (brand name Zytiga) used to treat metastatic prostate cancer. The company will sell abiraterone to

Read More »

News Alert

Boehringer Ingelheim Expands its 340B Drug Pricing Restrictions

Boehringer Ingelheim wordmark and logo mounted on building
Boehringer Ingelheim said on Friday that health centers will be subject to its limits on 340B pricing involving contract pharmacies starting Sept. 1.

Drug manufacturer Boehringer Ingelheim (BI) said on Friday that health centers will be subject to its limits on 340B pricing involving contract pharmacies starting Sept. 1. The restrictions previously applied to hospitals only. “At this time, for all other federal

Read More »

Providers March on U.S. Capitol Grounds to “Defend 340B”

340B program advocates with signs in front of the US Capitol building
Safety-net provider advocates marched on the U.S. Capitol grounds yesterday to raise awareness about threats to the 340B drug pricing program.

About 100 safety-net provider advocates marched and chanted yesterday on the grounds of the U.S. Capitol to raise awareness in Congress and beyond about threats to the 340B drug pricing program.

The demonstration, organized by Community Voices for 340B (CV340B),

Read More »

Ex-Surgeon General Adams Urges 340B Entities to Publicize Program’s Benefits

Former U.S. Surgeon General Jerome Adams speaking at a conference
Ex-U.S. Surgeon General Jerome Adams urged 340B Coalition summer conference attendees to show they "are fighting to deliver care to the vulnerable and to the underserved." | Credit: 340B Coalition Twitter

Healthcare providers can suppress attacks on and build support for the 340B program by doing more to show the program helps vulnerable patients, the anesthesiologist who served as President Trump’s surgeon general said yesterday.

“We are fighting to deliver care

Read More »

340B Hospitals Ask Judge to Stop Part B Drug Payment Cuts Immediately

hypodermic needle and glass ampule
Groups that represent 340B hospitals asked a federal district judge to immediately halt a nearly 30% Medicare Part B payment cut for hospitals’ 340B-purchased drugs.

Groups that represent 340B hospitals yesterday asked a federal district judge in Washington, D.C., to immediately halt a nearly 30% Medicare Part B payment cut in place since 2018 for hospitals’ 340B-purchased drugs.

American Hospital Association, America’s Essential Hospitals, Association

Read More »

New PhRMA-Funded Study Questions 340B Hospital Eligibility Yardstick

bar charts of percent of claims of inpatients and outpatients in 2020
New PhRMA-funded research shows that Medicare beneficiaries who were inpatients at 340B DSH hospitals were approximately 35% more likely to have the Part D Low Income Subsidy (LIS) and to be dually eligible for Medicare and Medicaid than were beneficiaries served on an outpatient basis.

Patients receiving inpatient care at 340B disproportionate share hospitals are significantly more likely to be low income than those receiving outpatient care, according to a new study funded by the brand name drug trade group PhRMA.

Hospital eligibility in the

Read More »

340B INDUSTRY LEADER SPOTLIGHT

William A. Riley, Senior Director, Health Systems Solutions & Decision Science, AllianceRx Walgreens Pharmacy

William A. Riley headshot
William A. Riley, Senior Director, Health Systems Solutions & Decision Science, AllianceRx Walgreens Pharmacy
William A. Riley

Q: Where did you grow up?

I had the honor to grow up with both of my parents serving in the Air Force so we did move around a fair amount in my younger years. However, I spent the majority of my childhood in Tuscola, IL, just 30 minutes from Champaign, home of University of Illinois.

Q:

Read More »

Purdue Pharma Is Providing 340B Refunds Spanning 16 Years of Overcharges

A bottle of Betasept antiseptic scrub
Purdue Pharma announced refunds for 340B overcharges on Betasept antiseptic surgical scrub for purchases spanning 16 years—more than half of the 340B program's existence.

Purdue Pharma’s Avrio Health subsidiary is giving 340B covered entities refunds for overcharges on Betasept antiseptic surgical scrub for purchases spanning 16 years—from Q2 2005 through Q2 2021. That period covers more than half of the 340B program’s existence.

During

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live